AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNLXdhaVRKY2VrQnZteVlCd1FjUnpyc2NpYUt5NG0wZERDU0ZraWU5blhMOXBrRWVZWU1vVUZTbE5XaTRpVFFpSEZNV3ZTaDlVTTdHTnkwY1dxcWx2bUpwU0xRS0E0MkNIVFVkYjA1d28zZGxJazh1OGtKTzJWeVE4TWFldTRKMS1FUzVnQ0J5QVpmTW5rQTVwWXREWkk2WkRDTjFOanI2eF9QQ0E0cWtER1Zxd3JHTDBOMkVkSXFQOThoMmlZTHd5Mi1HMWg2b3YtcHp0SVhORFl6b0EtZjZlNnhmaUY?oc=5" target="_blank">AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PM